FDA Approved: ARIKAYCE — Original Application (Insmed Incorporated)

View source ↗

Summary

The FDA approved ARIKAYCE (amikacin liposome inhalation suspension) from Insmed as the original approval for treatment-refractory Mycobacterium avium complex lu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycobacterium Avium Complex Lung Disease

Drugs mentioned

• Arikayce (amikacin liposome inhalation suspension)

Snippet

ORIG AP for ARIKAYCE (AMIKACIN)